The haemodynamic and myocardial effects of dopexamine: a new beta 2‐ adrenoceptor and dopaminergic agonist.

BE Jaski; W. Wijns; R. Foulds; PW Serruys

doi:10.1111/j.1365-2125.1986.tb05213.x

The haemodynamic and myocardial effects of dopexamine: a new beta 2‐ adrenoceptor and dopaminergic agonist.

BE Jaski
, W. Wijns
, R. Foulds
, PW Serruys

Medicine

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

35 Citations (Scopus)

Abstract

Dopexamine increases inotropic state and rate of relaxation independent of changes in heart rate. Dopexamine has a chronotropic effect and results in a decrease in systemic vascular resistance. Dopexamine has a spectrum of action that should be useful in patients with severe heart failure. 1986 The British Pharmacological Society

Original language	English
Pages (from-to)	393-400
Number of pages	8
Journal	British Journal of Clinical Pharmacology
Volume	21
Issue number	4
DOIs	https://doi.org/10.1111/j.1365-2125.1986.tb05213.x
Publication status	Published - Apr 1986

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1111/j.1365-2125.1986.tb05213.x

Cite this

@article{6d04556fcdb6469285dd39203546d1e6,

title = "The haemodynamic and myocardial effects of dopexamine: a new beta 2‐ adrenoceptor and dopaminergic agonist.",

abstract = "Dopexamine increases inotropic state and rate of relaxation independent of changes in heart rate. Dopexamine has a chronotropic effect and results in a decrease in systemic vascular resistance. Dopexamine has a spectrum of action that should be useful in patients with severe heart failure. 1986 The British Pharmacological Society",

author = "BE Jaski and W. Wijns and R. Foulds and PW Serruys",

year = "1986",

month = apr,

doi = "10.1111/j.1365-2125.1986.tb05213.x",

language = "English",

volume = "21",

pages = "393--400",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "4",

}

TY - JOUR

T1 - The haemodynamic and myocardial effects of dopexamine

T2 - a new beta 2‐ adrenoceptor and dopaminergic agonist.

AU - Jaski, BE

AU - Wijns, W.

AU - Foulds, R.

AU - Serruys, PW

PY - 1986/4

Y1 - 1986/4

N2 - Dopexamine increases inotropic state and rate of relaxation independent of changes in heart rate. Dopexamine has a chronotropic effect and results in a decrease in systemic vascular resistance. Dopexamine has a spectrum of action that should be useful in patients with severe heart failure. 1986 The British Pharmacological Society

AB - Dopexamine increases inotropic state and rate of relaxation independent of changes in heart rate. Dopexamine has a chronotropic effect and results in a decrease in systemic vascular resistance. Dopexamine has a spectrum of action that should be useful in patients with severe heart failure. 1986 The British Pharmacological Society

UR - https://www.scopus.com/pages/publications/0023031776

U2 - 10.1111/j.1365-2125.1986.tb05213.x

DO - 10.1111/j.1365-2125.1986.tb05213.x

M3 - Article

C2 - 2871852

AN - SCOPUS:0023031776

SN - 0306-5251

VL - 21

SP - 393

EP - 400

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 4

ER -

The haemodynamic and myocardial effects of dopexamine: a new beta 2‐ adrenoceptor and dopaminergic agonist.

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this